Virfast® - Pathogen Stack for Identification of DNA and RNA Viruses
Powered by AIoS™
Virfast®
Complete Viral Detection
From ICU diagnostics to outbreak investigation and surveillance, it enables assumption-free viral detection, delivering broad coverage and high-confidence identification when targeted assays are insufficient. Virfast® reduces diagnostic uncertainty and supports confident clinical decision-making.
It is a deployable diagnostic platform designed to support modern clinical care, outbreak preparedness, and pathogen surveillance.
Viral infections are diverse, rapidly evolving, and often clinically indistinguishable at presentation. Conventional viral diagnostics, including targeted PCR panels and serology, are inherently limited by pre-selection of targets, leaving gaps in detection. Virfast® provides unbiased, pan-viral detection without prior target selection.
Bactfast® integrates seamlessly with other detection kits:
Request Product Access
Clinical Applications
Virfast® is a screening test for critical conditions such as:
Acute febrile illness of unknown origin
ICU patients with unexplained systemic infection
Suspected viral sepsis or encephalitis
Outbreak and emerging pathogen detection
Viral–bacterial or viral–fungal co-infections
Negative or inconclusive targeted PCR results
The SOLUTION
How Virfast® Delivers Diagnostic Clarity
Virfast® uses next-generation sequencing and proprietary bioinformatics to deliver broad viral detection with high resolution. Designed for complex diagnostic scenarios, it provides comprehensive insight from a single test.
Metric | Virfast® | Targeted PCR Panels | Serology / Antigen Tests | Insight |
|---|---|---|---|---|
Detection Approach
| Metagenomic sequencing | Target-restricted | Host-response based | No prior assumptions required |
DNA & RNA Viruses
| Yes | Yes (limited) | No | One workflow covers both |
Organism Coverage
| 9,000+ viruses | Panel-dependent | Limited | Broadest viral spectrum |
Emerging / Novel Viruses
| Detectable | Not detectable | Not detectable | Future-proof detection |
Genotypic Resolution | High | Limited | Limited | Supports surveillance |
Connect with Credence Genomics to learn more about our detection kits.
Our Process
How Credence Genomics Detection Kits Work
Clinical samples are processed using validated wet-lab protocols designed to preserve microbial DNA while minimizing contamination. This ensures consistent, high-quality input across diverse sample types.
Next-generation sequencing captures the full microbial landscape within each sample. Proprietary bioinformatics and machine learning algorithms identify pathogens while separating commensal organisms and contaminants.
Results are delivered in a clear, structured format—providing species-level identification and clinically relevant insights that support informed treatment decisions and faster patient care for your needs.